Tectonic Therapeutic (TECX) Debt Ratio (2021 - 2023)

Tectonic Therapeutic (TECX) reported Debt Ratio of 0.19 for Q1 2023, up 115.97% year-over-year from 0.09 in Q1 2022, and up 25.89% quarter-over-quarter from 0.15 in Q4 2022.

Tectonic Therapeutic (TECX) Debt Ratio (2021 - 2023) Analysis & Trends

Tectonic Therapeutic (TECX) has 3 years of Debt Ratio data on file, last reported at 0.19 in Q1 2023.

  • Debt Ratio for Q1 2023 came in at 0.19, up 115.97% year-over-year; the trailing twelve-month figure through Mar 2023 was 0.19 (up 115.97% YoY), and the FY2022 annual result was 0.15, up 100.44% from the prior year.
  • Debt Ratio advanced to 0.19 in Q1 2023 per TECX's latest filing, from 0.15 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.19 in Q1 2023 and troughed at 0.07 in Q4 2021.
  • A 3-year average of 0.12 and a median of 0.11 in 2022 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2022 and 2023: Debt Ratio jumped 100.44% in 2022, then surged 115.97% in 2023.
  • A 3-year view of Debt Ratio shows it stood at 0.07 in 2021, then jumped by 100.44% to 0.15 in 2022, then increased by 25.89% to 0.19 in 2023.
  • Business Quant data shows TECX's Debt Ratio at 0.19 in Q1 2023, 0.15 in Q4 2022, and 0.12 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.18
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Tectonic Therapeutic 528.16 Mn 291.27 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.19
Dec 31, 2022 0.15
Sep 30, 2022 0.12
Jun 30, 2022 0.10
Mar 31, 2022 0.09
Dec 31, 2021 0.07